p38 and JNK MAPK, but not ERK1/2 MAPK, play important role in colchicine-induced cortical neurons apoptosis

European Journal of Pharmacology

Volumn 576, Issue 1-3, 2007, Pages 26-33

  Yang, Yi ^a   Zhu, Xiaonan ^a   Chen, Yuanbin ^a   Wang, Xuelan ^a   Chen, Ruzhu ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Colchicine; Cortical neuron; ERK1 2 MAPK; JNK MAPK; p38 MAPK

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 [4 (4 FLUOROPHENYL) 5 (2 METHOXY 4 PYRIMIDINYL) 1 IMIDAZOLYL]CYCLOHEXANOL; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; COLCHICINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PACLITAXEL; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; ATTENUATION; BRAIN CELL; DRUG EXPOSURE; ENZYME ACTIVATION; ENZYME INHIBITION; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; COLCHICINE; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 35348830412     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.07.067     Document Type: Article

References (32)

1. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., and Saltiel A.R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J. Biol. Chem. 270 (1995) 27489-27494
2. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., and Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. 98 (2001) 13681-13686
3. Bonfoco E., Ceccatelli S., Manzo L., and Nicotera P. Colchicine induces apoptosis in cerebellar granule cells. Exp. Cell Res. 218 (1995) 189-200
4. Cowan W.M., Fawcett J.W., O'Leary D.D., and Stanfield B.B. Regressive events in neurogenesis. Science 225 (1984) 1258-1265
5. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., and Lee J.C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364 (1995) 229-233
6. Davies P., Katzman R., and Terry R.D. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. Nature 288 (1980) 279-280
7. Ebert A.D., and Svendsen C.N. A new tool in the battle against Alzheimer's disease and aging: ex vivo gene therapy. Rejuvenation Res. 8 (2005) 131-134
8. Ekshyyan O., and Aw T.Y. Apoptosis: a key in neurodegenerative disorders. Curr. Neurovasc. Res. 1 (2004) 355-371
9. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., and Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase. J. Biol. Chem. 273 (1998) 18623-18632
10. Fonfria E., Dare E., Benelli M., Sunol C., and Ceccatelli S. Translocation of apoptosis-inducing factor in cerebellar granule cells exposed to neurotoxic agents inducing oxidative stress. Eur. J. Neurosci. 16 (2002) 2013-2016
11. Furukawa K., and Mattson M.P. Taxol stabilizes [Ca2+]i and protects hippocampal neurons against excitotoxicity. Brain Res. 689 (1995) 141-146
12. Gorman A.M., Bonfoco E., Zhivotovsky B., Orrenius S., and Ceccatelli S. Cytochrome c release and caspase-3 activation during colchicine-induced apoptosis of cerebellar granule cells. Eur. J. Neurosci. 11 (1999) 1067-1072
13. Jorda E.G., Verdaguer E., Canudas A.M., Jimenez A., Bruna A., Caelles C., Bravo R., Escubedo E., Pubill D., Camarasa J., Pallas M., and Camins A. Neuroprotective action of flavopiridol, a cyclin-dependent kinase inhibitor, in colchicine-induced apoptosis. Neuropharmacology 45 (2003) 672-683
14. Jorda E.G., Verdaguer E., Jimenez A., Canudas A.M., Rimbau V., Camps P., Munoz-Torrero D., Camins A., and Pallas M. (+/-)-huprine Y, (-)-huperzine A and tacrine do not show neuroprotective properties in an apoptotic model of neuronal cytoskeletal alteration. J. Alzheimer's Dis. 6 (2004) 577-583
15. Jordan M.A., and Wilson L. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr. Opin. Cell Biol. 10 (1998) 123-130
16. Mirsky R., Wendon L.M., Black P., Stolkin C., and Bray D. Tetanus toxin: a cell surface marker for neurones in culture. Brain Res. 148 (1978) 251-259
17. Muller G.J., Geist M.A., Veng L.M., Willesen M.G., Johansen F.F., Leist M., and Vaudano E. A role for mixed lineage kinases in granule cell apoptosis induced by cytoskeletal disruption. J. Neurochem. 96 (2006) 1242-1252
18. Murakata C., Kaneko M., Gessner G., Angeles T.S., Ator M.A., O'Kane T.M., McKenna B.A., Thomas B.A., Mathiasen J.R., Saporito M.S., Bozyczko-Coyne D., and Hudkins R.L. Mixed lineage kinase activity of indolocarbazole analogues. Bioorg. Med. Chem. Lett. 12 (2002) 147-150
19. Oppenheim R.W. Cell death during development of the nervous system. Annu. Rev. Neurosci. 14 (1991) 453-501
20. Raff M.C., Barres B.A., Burne J.F., Coles H.S., Ishizaki Y., and Jacobson M.D. Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262 (1993) 695-700
21. Seger R., and Krebs E.G. The MAPK signaling cascade. FASEB J. 9 (1995) 726-735
22. Sennvik K., Benedikz E., Fastbom J., Sundstrom E., Winblad B., and Ankarcrona M. Calcium ionophore A23187 specifically decreases the secretion of beta-secretase cleaved amyloid precursor protein during apoptosis in primary rat cortical cultures. J. Neurosci. Res. 63 (2001) 429-437
23. Shen Y.H., Godlewski J., Zhu J., Sathyanarayana P., Leaner V., Birrer M.J., Rana A., and Tzivion G. Cross-talk between JNK/SAPK and ERK/MAPK pathways: sustained activation of JNK blocks ERK activation by mitogenic factors. J. Biol. Chem. 18 (2003) 26715-26721
24. Shimohama S. Apoptosis in Alzheimer's disease-an update. Apoptosis 5 (2000) 9-16
25. Skoufias D.A., and Wilson L. Mechanism of inhibition of microtubule polymerization by colchicine: inhibitory potencies of unliganded colchicine and tubulin-colchicine complexes. Biochemistry 28 (1992) 738-746
26. Stefanis L., Burke R.E., and Greene L.A. Apoptosis in neurodegenerative disorders. Curr. Opin. Neurol. 10 (1997) 299-305
27. Stone A.A., and Chambers T.C. Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells. Exp. Cell Res. 254 (2000) 110-119
28. Subbaramaiah K., Hart J.C., Norton L., and Dannenberg A.J. Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 AND p38 mitogen-activated protein kinase pathways. J. Biol. Chem. 275 (2000) 14838-14845
29. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267 (1995) 1456-1462
30. Underwood D.C., Osborn R.R., Kotzer C.J., Adams J.L., Lee J.C., Webb E.F., Carpenter D.C., Bochnowicz S., Thomas H.C., Hay D.W., and Griswold D.E. SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. J. Pharmacol. Exp. Ther. 293 (2000) 281-288
31. Volbracht C., Leist M., Kolb S.A., and Nicotera P. Apoptosis in caspase-inhibited neurons. Mol. Med. 7 (2001) 36-48
32. Xia Z., Dickens M., Raingeaud J., Davis R.J., and Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 24 (1995) 1326-1331